arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Programme

Thursday 10 Nov

08:30

Registration

09:00

Opening/Welcome

René Leemans/Andreas Dietz/Wojciech Golusinski

Epidemiology and carcinogenesis

Chairs: Andreas Dietz/Wojciech Golusinski

09:20

Epidemiology of oral/oropharyngeal HPV infection

Maura Gillison

09:40

HPV-mediated carcinogenesis

Ruud Brakenhoff

10:00

Worldwide incidence of HPV in OPSCC

Pawel Golusinski

10:20

Coffee

10:15

Mucosal stem cells and HPV infection

Jochen Hess

11:10

Free papers 4x

Prognosis and serology HPV in OPSCC

Chairs: Ruud Brakenhoff/ Maura Gillison

11:50

Validation of statistical models for OPSCC

Robert Baatenburg de Jong

12:10

Subclassification of HPV-OPSCC by gene expression

Lisa Licitra

12:30

HPV early antigen serology and OPC screening

Tim Waterboer

12:45

Antibody producing B-cells in HPV+ve OPSCC: an overview

Rieneke van de Ven

13:00

Lunch

Treatment of HPV+ve OPSCC

Chairs: René Leemans/Bob Ferris

14:00

Treatment of HPV disease by transoral robotic surgery

Christian Simon

14:20

Treatment of HPV disease by laser surgery

Terry Jones

14:40

Treatment of HPV disease with (chemo)radiotherapy

Vincent Gregoire

15:00

Free papers 3x

15:30

Coffee

T.B.C.

Chairs: Christian Simon/Stephan Lang

16:00

Are there alternatives for 3 weekly cisplatin in HPV disease?

Jan Vermorken

16:20

Salvage surgery for HPV disease

Carole Fakhry

Debate

16:40

Debate: This house believes that TNM8 was implemented too early for HPV+ve OPSCC

For: Hisham Mehanna / Against: Brian O’Sullivan

17:00

Posters and Drinks

Friday 11 Nov

Therapy developments in HPV+ve OPSCC

Chairs: Jan Vermorken/Vincent Gregoire

09:00

Free papers 3x

09:30

De-escalation of non-surgical therapy

Hisham Mehanna

09:50

De-escalation using surgery

Bob Ferris

10:10

Is proton therapy preferable for HPV+ve OPSCC?

Hans Langendijk

10:30

Coffee

T.B.C.

Chairs: Lisa Licitra/Hans Langendijk

11:00

Free papers 2x

11:20

Next generation robotics

Stephan Lang

11:40

Immunotherapy for HPV-driven disease

Maura Gillison

12:00

Tumor board (moderator: Terry Jones)

Wojciech Golusinski, Stephan Lang, Hans Langendijk, Lisa Licitra, Bob Ferris

13:00

Lunch

Future perspectives in HPV research

Chairs: Rieneke van de Ven/Ingeborg Tinhofer-Keilholz

14:00

Therapeutic HPV vaccination

Sjoerd van der Burg

14:20

HPV in non-oropharygeal HNSCC: does it play a role?

Gunnar Wichmann

14:40

Free papers 3x

Screening and Prevention

Chair: Andreas Dietz

15:10

Round table screening and prevention

Discussion leader: Andreas Dietz

5-slide Pitch Hans Berkhof: Preventive vaccination, also in treated OPSCC patients?
5-slide Pitch Tim Waterboer: HPV serology for screening
5-slide Pitch Ingeborg Tinhofer-Keilholz: HPV DNA assays for screening
5-slide Pitch Carole Fakhry: Positively screened for HPV: which intervention?

16:00

Round table discussion: screening and prevention

16:30

Summary

Wojciech Golusinski

16:40

Free paper/Poster awards and closing remarks

René Leemans

16:50

Adjourn